Skip to content

CHINA PHARMA HOLDINGS, INC.: 10-Q filed 2018-11-14

What CHINA PHARMA HOLDINGS, INC. reported in its quarterly report filed 2018-11-14 (fiscal Q3 2018): 43 published measures, 121 facts as tagged in accession 0001213900-18-015783.

This filing

Form
10-Q (quarterly report)
Filed
2018-11-14
Fiscal period
fiscal Q3 2018
Accession
0001213900-18-015783 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CHINA PHARMA HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-09-3052,534,740USD
At 2017-12-3159,952,900USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2018-09-3014,901,617USD
At 2017-12-3116,881,598USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-09-3037,633,123USD
At 2017-12-3143,071,302USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2018-09-30667,629USD
At 2017-12-312,030,214USD
At 2017-09-301,124,439USD
At 2016-12-312,665,802USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-1,856,519USD92
2018-01-01 to 2018-09-30-3,158,048USD273
2017-07-01 to 2017-09-30-2,195,428USD92
2017-01-01 to 2017-09-30-5,450,236USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2018-01-01 to 2018-09-301,007,688USD273
2017-01-01 to 2017-09-30-95,547USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2018-01-01 to 2018-09-3033,332USD273
2017-01-01 to 2017-09-3067,324USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2018-07-01 to 2018-09-302,298,472USD92
2018-01-01 to 2018-09-309,087,867USD273
2017-07-01 to 2017-09-303,162,222USD92
2017-01-01 to 2017-09-309,364,605USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2018-01-01 to 2018-09-30-2,303,410USD273
2017-01-01 to 2017-09-30-1,469,349USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2018-01-01 to 2018-09-30-33,332USD273
2017-01-01 to 2017-09-30-67,324USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-09-302,321,761USD
At 2017-12-315,479,809USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-160,485USD92
2018-01-01 to 2018-09-30-111,910USD273
2017-07-01 to 2017-09-3031,198USD92
2017-01-01 to 2017-09-3092,106USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2018-09-3020,056,635USD
At 2017-12-3123,541,003USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-1,931,434USD92
2018-01-01 to 2018-09-30-2,936,524USD273
2017-07-01 to 2017-09-30-2,055,361USD92
2017-01-01 to 2017-09-30-4,989,441USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-09-309,710,391USD
At 2017-12-3112,290,087USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2018-07-01 to 2018-09-30101,683USD92
2018-01-01 to 2018-09-30361,365USD273
2017-07-01 to 2017-09-30130,816USD92
2017-01-01 to 2017-09-30411,985USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2018-09-309,767,124USD
At 2017-12-319,227,132USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2018-09-30289,054USD
At 2017-12-31398,856USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2018-07-01 to 2018-09-302,443,979USD92
2018-01-01 to 2018-09-305,082,250USD273
2017-07-01 to 2017-09-302,476,900USD92
2017-01-01 to 2017-09-306,777,190USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2018-09-306,099,999USD
At 2017-12-316,407,155USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2018-07-01 to 2018-09-30512,545USD92
2018-01-01 to 2018-09-302,145,726USD273
2017-07-01 to 2017-09-30421,539USD92
2017-01-01 to 2017-09-301,787,749USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2018-07-01 to 2018-09-301,785,927USD92
2018-01-01 to 2018-09-306,942,141USD273
2017-07-01 to 2017-09-302,740,683USD92
2017-01-01 to 2017-09-307,576,856USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2018-07-01 to 2018-09-3062,059USD92
2018-01-01 to 2018-09-30107,946USD273
2017-07-01 to 2017-09-3027,543USD92
2017-01-01 to 2017-09-3075,053USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-09-3043,579,557shares
At 2017-12-3143,579,557shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2018-09-3023,590,204USD
At 2017-12-3123,590,204USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2018-09-3011,677,578USD
At 2017-12-3113,957,709USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2018-09-306,553,524USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2018-09-3037,044,614USD
At 2017-12-3139,061,837USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2018-09-3016,987,979USD
At 2017-12-3115,520,834USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2018-09-30289,054USD
At 2017-12-31398,856USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2018-09-30182,692USD
At 2017-12-31276,368USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-2,017,004USD92
2018-01-01 to 2018-09-30-3,269,958USD273
2017-07-01 to 2017-09-30-2,164,230USD92
2017-01-01 to 2017-09-30-5,358,130USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-3,391,943USD92
2018-01-01 to 2018-09-30-5,438,179USD273
2017-07-01 to 2017-09-30-112,030USD92
2017-01-01 to 2017-09-30-1,878,356USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2018-07-01 to 2018-09-30327,161USD92
2018-01-01 to 2018-09-301,172,314USD273
2017-07-01 to 2017-09-30348,963USD92
2017-01-01 to 2017-09-301,377,640USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2018-07-01 to 2018-09-30942,555USD92
2018-01-01 to 2018-09-302,405,396USD273
2017-07-01 to 2017-09-30779,856USD92
2017-01-01 to 2017-09-302,314,928USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2018-01-01 to 2018-09-302,499,114USD273
2017-01-01 to 2017-09-302,447,866USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2018-07-01 to 2018-09-3026,861USD92
2018-01-01 to 2018-09-3093,718USD273
2017-07-01 to 2017-09-3039,630USD92
2017-01-01 to 2017-09-30132,938USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-85,570USD92
2018-01-01 to 2018-09-30-333,434USD273
2017-07-01 to 2017-09-30-108,869USD92
2017-01-01 to 2017-09-30-368,689USD273

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-181,524USD92
2018-01-01 to 2018-09-30-181,524USD273

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2018-07-01 to 2018-09-3021,039USD92
2018-01-01 to 2018-09-3069,614USD273
2017-07-01 to 2017-09-3031,198USD92
2017-01-01 to 2017-09-3092,106USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2018-01-01 to 2018-09-30351,206USD273
2017-01-01 to 2017-09-30410,509USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2018-07-01 to 2018-09-300USD92
2018-01-01 to 2018-09-300USD273
2017-07-01 to 2017-09-300USD92
2017-01-01 to 2017-09-300USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-09-30-471,995USD273
2017-01-01 to 2017-09-30-1,237,573USD273

Inspect the source

Entity
CHINA PHARMA HOLDINGS, INC. / CIK 0001106644
Captured
2026-09-20T05:23:28.377Z
SEC response SHA-256
ad45dffd15d0f5a098ab8b6912816a8b1b845b1d791781ea412833d3178873c0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001106644.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))